Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
31.67 USD | -0.03% |
|
-0.47% | +2.89% |
06-13 | Collegium Pharmaceutical Says Nucynta Gets FDA Pediatric Exclusivity | MT |
06-13 | Collegium Pharmaceutical, Inc. Obtains Six Month Extension of U.S. Pediatric Exclusivity for Nucynta Franchise | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+2.89% | 1.04B | |
+52.70% | 801B | |
+41.58% | 631B | |
-4.86% | 359B | |
+21.96% | 337B | |
+11.47% | 305B | |
+17.72% | 245B | |
+4.46% | 231B | |
+13.13% | 219B | |
+10.46% | 171B |
- Stock Market
- Equities
- COLL Stock
- News Collegium Pharmaceutical, Inc.
- Earnings Flash (COLL) COLLEGIUM PHARMACEUTICAL Reports Q4 EPS $1.58, vs. Street Est of $1.26